体育投注

Breakthroughs that change patients' lives

Chairman & CEO Letter

by Dr. Albert Bourla
At Pfizer, our work is not complete until our medicines and vaccines reach patients’ hands. So we are leading the conversation to create healthcare policies that promote R&D innovation and more importantly, improve patient access and affordability. As an example, we are a strong advocate of value-based partnerships – rewarding providers for quality not quantity – and are actively engaging with key stakeholders in Japan, China, and Europe to champion these outcomes-based healthcare models.

Sally Susman

Executive Vice President and Chief Corporate Affairs Officer
Lead the conversation